Bionano Genomics, Inc. (BNGO): Balans kapitallashuviga qarzlar

Bionano Genomics Inc. (BNGO) tovar belgisi

Qarzning kitob qiymatiga nisbati Bionano Genomics, Inc. (BNGO) moliyaviy barqarorligini namoyish etadi, bunda 0.22 qiymati joriy ko'rsatkichni ifodalaydi. Saphyr texnologiyasi DNK tahlilining a’lo darajadagi aniqligini ta’minlab, noyob raqobatbardoshlik ustunligini yaratadi. Biroq, naqd pullarning tez sarflanishi va raqobat xatarlarni keltirib chiqarmoqda. Shu bilan birga, davlat budjetlarining qisqarishi biznesni chegirmalar va uskunalarni moslashuvchan lizingga berishni joriy etishga majbur qilmoqda.

BNGO - Bionano Genomics Inc. Sof aktivlarga qarzlar 04.07.2022 - 28.10.2026 oraligʻida

bionanogenomics.com (BNGO) kompaniyasi koʻrsatkichlari kesimi va tahlili

- narx va narxlar bo'yicha konsensus prognoz:
Aksiya narxi Bionano Genomics|BNGO - Tahlilchilar konsensus prognozi
- bozor kapitallashuvi bo'yicha ma'lumotlar:
Bozor kapitallashuvi Bionano Genomics|BNGO - Kompaniyaning to‘liq qiymati
- balans kapitallashuvi bo'yicha ma'lumotlar:
Bitta aksiya hisobiga balans qiymati Bionano Genomics|BNGO - Biznesning balans bahosi|Bozor qiymatining balans qiymatiga nisbati bionanogenomics.com|BNGO - Kompaniya aktivlari
- qarz va likvidlik bo'yicha ma'lumotlar:
Qarzning xususiy kapitalga nisbati Bionano Genomics, Inc.|BNGO - Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi|Qisqa muddatli qarzning kapitalga nisbati Bionano Genomics|BNGO - Kompaniyaning jamlangan qarzlari|Qarzning balans kapitallashuviga nisbati Bionano Genomics|BNGO - Kompaniyaning uzoq muddatli qarzdorligi|Kompaniyaning qisqa muddatli qarzi Bionano Genomics
Kompaniyaning jamlanma tahliliyoti:BNGO - Bionano
bionanogenomics.com seriyali mahsuloti

Ushbu ko'rsatkich umumiy majburiyatlarning kapitalga nisbati sifatida hisoblanadi va moliyaviy barqarorlikning operatsion samaradorlikka bog'liqligini aks ettiradi. Metrika defolt risklarini va o'sish potentsialini baholash uchun biznesning leveraj darajasini o'lchaydi. Bionano Genomics, Inc. (BNGO) yuqori aniqlikdagi genom xaritalash sohasidagi o'z o'rnini himoya qilish uchun qarz kapitalidan foydalanadi. GURU.Markets orqali balansdagi joriy leveraj nisbatini tahlil qilish hisobotlar orasidagi qarz yuklamasini kuzatish imkonini beradi. Ushbu koeffitsiyentning kamayishi emitentning moliyaviy avtonomiyasini tasdiqlaydi.

Bionano Genomics, Inc. kimlar bilan raqobatlashadi

Balans kapitallashuviga qarzlar TEM (Tempus AI Inc)|Balans kapitallashuviga qarzlar qiagen.com QGEN|IONS - Balans kapitallashuviga qarzlar|RGEN - Qarzning balans kapitallashuviga nisbati|Avidity - Balans kapitallashuviga qarzlar|CRSP (CRISPR) - Sof aktivlarga qarzlar|Qarzning balans kapitallashuviga nisbati WGS (GeneDx Holdings Corp.)|Balans qiymatiga qarzlar RARE|Qarzning balans kapitallashuviga nisbati Beam Therapeutics BEAM|Qarzning balans qiymatiga nisbati Sarepta Therapeutics (SRPT)|Balans kapitallashuviga qarzlar TWST (Twist Bio)|10x - Balans kapitallashuviga qarzlar|Intellia Therapeutics (NTLA) - Qarzning balans kapitallashuviga nisbati|STOK: Qarzning balans qiymatiga nisbati|Qarzning balans kapitallashuviga nisbati BLFS|Balans qiymatiga qarzlar Wave Life Sciences Ltd|MAZE - Qarzning balans qiymatiga nisbati|Qarzning sof aktivlarga nisbati Sionna Corp|PRME: Balans kapitallashuviga qarzlar|Qarzning sof aktivlarga nisbati tayshagtx.com (TSHA)|QURE: Balans kapitallashuviga qarzlar|MeiraGTx Holdings - Balans qiymatiga qarzlar|Regenxbio (RGNX) - Qarzning balans kapitallashuviga nisbati|SLDB: Qarzning balans qiymatiga nisbati|Qarzning balans kapitallashuviga nisbati OCGN|PACB (pacb.com) - Balans qiymatiga qarzlar|Qarzning balans kapitallashuviga nisbati BNTC|Qarzning balans qiymatiga nisbati Design Therapeutics Inc|RCKT (Rocket Pharmaceuticals Inc) - Balans kapitallashuviga qarzlar|Sof aktivlarga qarzlar 4D Molecular Corp (FDMT)|Lexeo Therapeutics, Inc. - Balans kapitallashuviga qarzlar|Korro Bio Inc. - Qarzning balans qiymatiga nisbati|Qarzning balans kapitallashuviga nisbati EDIT (Editas Medicine)|Silence Therapeutics PLC (SLN) - Sof aktivlarga qarzlar|Qarzning balans qiymatiga nisbati proqr.com PRQR|Codexis (CDXS) - Qarzning sof aktivlarga nisbati|SGMO: Balans kapitallashuviga qarzlar|Sof aktivlarga qarzlar NAUT|Qarzning balans kapitallashuviga nisbati Metagenomi MGX|Qarzning balans qiymatiga nisbati Precision BioSciences Inc. (DTIL)|Generation Bio - Balans kapitallashuviga qarzlar|BOLD - Qarzning balans qiymatiga nisbati|Qarzning balans qiymatiga nisbati XCUR (Exicure Corp)|IMNN - Sof aktivlarga qarzlar|phiopharma.com (PHIO) - Balans kapitallashuviga qarzlar|MBIO (Mustang Bio) - Qarzning balans kapitallashuviga nisbati|Qarzning balans kapitallashuviga nisbati TransCode Therapeutics Inc. (RNAZ)|Qarzning balans qiymatiga nisbati Applied DNA Corp|BLUE: Balans kapitallashuviga qarzlar|Qarzning sof aktivlarga nisbati IPA (immunoprecise.com)|OMGA: Qarzning balans kapitallashuviga nisbati|Balans qiymatiga qarzlar Singular Genomics Systems, Inc. OMIC|Regulus Therapeutics Inc (RGLS) - Balans kapitallashuviga qarzlar|SYRS: Qarzning balans qiymatiga nisbati|Qarzning balans kapitallashuviga nisbati Telesis Bio, Inc.|traconpharma.com (TCON) - Qarzning balans qiymatiga nisbati|UBX (Unity Biotechnology, Inc.) - Balans kapitallashuviga qarzlar